NDC 44911-0191

CARCINOSIN CORD

Carcinosin

CARCINOSIN CORD is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Energique, Inc.. The primary component is Human Breast Tumor Cell.

• Product ID: 44911-0191_22a67d66-1992-4fe8-a8f9-84f0c00762cb
• NDC: 44911-0191
• Product Type: Human Otc Drug
• Proprietary Name: CARCINOSIN CORD
• Generic Name: Carcinosin
• Dosage Form: Liquid
• Route of Administration: ORAL
• Marketing Start Date: 2015-07-09
• Marketing Category: UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
• Labeler Name: Energique, Inc.
• Substance Name: HUMAN BREAST TUMOR CELL
• Active Ingredient Strength: 12 [hp_X]/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 44911-0191-1

30 mL in 1 BOTTLE, DROPPER (44911-0191-1)

• Marketing Start Date: 2015-07-09
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 44911-0191-1 [44911019101]

CARCINOSIN CORD LIQUID

• Marketing Category: unapproved homeopathic
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-07-09

Drug Details

Active Ingredients

Ingredient	Strength
HUMAN BREAST TUMOR CELL	12 [hp_X]/mL

OpenFDA Data

• SPL SET ID: 9c45e98c-c2b5-4a8d-9891-e96e13fbc935
• Manufacturer:
  • Energique, Inc.
• UNII:
  • C62OO7VD9K

NDC Crossover Matching brand name "CARCINOSIN CORD" or generic name "Carcinosin"

NDC	Brand Name	Generic Name
44911-0191	CARCINOSIN CORD	Carcinosin
44911-0530	CARCINOSIN CORD	Carcinosin
43742-0208	Carcinosin	Carcinosin
43742-0676	Carcinosin	Carcinosin